CH EPL (R5)
1.0.0-ballot - ballot
This page is part of the CH EPL (R5) (v1.0.0-ballot: DSTU 1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version. For a full list of available versions, see the Directory of published versions
Generated Narrative: RegulatedAuthorization FOPH-17973
CH - EPL Reimbursement SL
- FOPHDossierNumber: FOPH Dossier Number/17973
- status: Reimbursed
- statusDate: 2004-02-01
- listingStatus: Listed
- listingPeriod: 2004-02-01 --> (ongoing)
- firstListingDate: 2004-02-01
- costShare: 10
- gamme: Rectal Vaginal
CH - EPL Product Price
- value: CHF40.89 (CHF)
- type: Ex-factory price
- changeType: Price mutation after triennal review of pharmaceuticals
- changeDate: 2023-12-01
CH - EPL Product Price
- value: CHF63.40 (CHF)
- type: Retail price
- changeType: VAT-change
- changeDate: 2024-01-01
type: Reimbursement SL
| Extension | Reference |
| ClinicalUseDefinition: type = indication |
holder: Organization Tillotts Pharma AG
Generated Narrative: Organization #holder-Tillotts-Pharma-AG
Profile: CH EPL Organization
identifier: LOC Identifier/100005174, GLN Identifier/7601001346451
name: Tillotts Pharma AG